Characterization of low- and very-low-density hepatitis C virus RNA-containing particles

Journal of Virology

Volumn 76, Issue 14, 2002, Pages 6919-6928

  Andre P ^a   Komurian Pradel, F ^b   Deforges, S ^a   Perret, M ^a   Berland, J L ^b   Sodoyer, M ^b   Pol, S ^a   Brechot C ^a   Paranhos Baccala G ^b   Lotteau, V ^a  

^a INSERM   (France)

^b BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CORE PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN ANTIBODY; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VIRUS PROTEIN; VIRUS RNA; HEPATITIS C ANTIBODY; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN;

ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS CHARACTERIZATION; VIRUS PARTICLE; BLOOD; CELL CULTURE; ELECTRON MICROSCOPY; HUMAN; ISOLATION AND PURIFICATION; PATHOGENICITY; PHYSIOLOGY; VIRION; VIROLOGY;

HEPATITIS C VIRUS; MIRIDAE;

HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MICROSCOPY, ELECTRON; RNA, VIRAL; TUMOR CELLS, CULTURED; VIRION;

EID: 19044396066     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.14.6919-6928.2002     Document Type: Article

References (45)

1. Agnello, V. 1997. Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. Hepatology 26:1375-1379.
2. Agnello, V., G. Abel, M. Elfahal, G. B. Knight, and Q. X. Zhang. 1999. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96:12766-12771.
3. Barba, G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura, and C. Brechot. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA 94:1200-1205.
4. Besnard, N. C., and P. M. Andre. 1994. Automated quantitative determination of hepatitis C virus viremia by reverse transcription-PCR. J. Clin. Microbiol. 32:1887-1893.
5. Bradley, D., K. McCaustland, K. Krawczynski, J. Spelbring, C. Humphrey, and E. H. Cook. 1991. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J. Med. Virol. 34:206-208.
6. Brown, M. S., R. G. Anderson, and J. L. Goldstein. 1983. Recycling receptors: the round-trip itinerary of migrant membrane proteins. Cell 32:663-667.
7. Carrick, R. J., G. G. Schlauder, D. A. Peterson, and I. K. Mushahwar. 1992. Examination of the buoyant density of hepatitis C virus by the polymerase chain reaction. J. Virol. Methods 39:279-289.
8. Choo, S. H., H. S. So, J. M. Cho, and W. S. Ryu. 1995. Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. J. Gen. Virol. 76:2337-2341.
9. Cocquerel, L., J. C. Meunier, A. Pillez, C. Wychowski, and J. Dubuisson. 1998. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J. Virol. 72:2183-2191.
10. Duvet, S., L. Cocquerel, A. Pillez, R. Cacan, A. Verbert, D. Moradpour, C. Wychowski, and J. Dubuisson. 1998. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J. Biol. Chem. 273:32088-32095.
11. Farci, P., A. Shimoda, D. Wong, T. Cabezon, D. De Gioannis, A. Strazzera, Y. Shimizu, M. Shapiro, H. J. Alter, and R. H. Purcell. 1996. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 93:15394-15399.
12. Garson, J. A., D. Lubach, J. Passas, K. Whitby, and P. R. Grant. 1999. Suramin blocks hepatitis C binding to human hepatoma cells in vitro. J. Med. Virol. 57:238-242.
13. Goldstein, J. L., M. K. Sobhani, J. R. Faust, and M. S. Brown. 1976. Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus. Cell 9:195-203.
14. Havel, R. J., and J. P. Kane. 1995. Introduction: structure and metabolism of plasma lipoproteins, p. 18416-18451. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Walle (ed.), The metabolic and molecular bases of inherited diseases, 7th ed. McGraw-Hill Book Co., New York, N.Y.
15. Hijikata, M., Y. K. Shimizu, H. Kato, A. Iwamoto, J. W. Shih, H. J. Alter, R. H. Purcell, and H. Yoshikura. 1993. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J. Virol. 67: 1953-1958.
16. Hoofnagle, J. H. 1997. Hepatitis C: the clinical spectrum of disease. Hepatology 26:15S-20S.
17. Ishida, S., M. Kaito, M. Kohara, K. Tsukiyama-Kohora, N. Fujita, J. Ikoma, Y. Adachi, and S. Watanabe. 2001. Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique. Hepatol. Res. 20:335-347.
18. Jolivet-Reynaud, C., P. Dalbon, F. Viola, S. Yvon, G. Paranhos-Baccala, N. Piga, L. Bridon, M. A. Trabaud, N. Battail, G. Sibai, and M. Jolivet. 1998. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection. J. Med. Virol. 56:300-309.
19. Kanto, T., N. Hayashi, T. Takehara, H. Hagiwara, E. Mita, M. Naito, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 19:296-302.
20. Kanto, T., N. Hayashi, T. Takehara, H. Hagiwara, E. Mita, M. Naito, A. Kasahara, H. Fusamoto, and T. Kamada. 1995. Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence. J. Hepatol. 22:440-448.
21. Kanto, T., N. Hayashi, T. Takehara, H. Hagiwara, E. Mita, M. Oshita, K. Katayama, A. Kasahara, H. Fusamoto, and T. Kamada. 1995. Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-alpha. J. Med. Virol. 46:230-237.
22. Komurian-Pradel, F., G. Paranhos-Baccala, M. Sodoyer, P. Chevallier, B. Mandrand, V. Lotteau, and P. Andre. 2001. Quantitation of HCV RNA using real-time PCR and fluorimetry. J. Virol. Methods 95:111-119.
23. Lodish, H. F., and M. Porter. 1980. Specific incorporation of host cell surface proteins into budding vesicular stomatitis virus particles. Cell 19:161-169.
24. Maillard, P., K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, and A. Budkowska. 2001. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 75:8240-8250.
25. Mills, G. L., P. A. Lane, and P. K. Weech. 1984. A guidebook to lipoprotein technique. Elsevier, Amsterdam, The Netherlands.
26. Milne, R., R. Theolis, Jr., R. Maurice, R. J. Pease, P. K. Weech, E. Rassart, J. C. Fruchart, J. Scott, and Y. L. Marcel. 1989. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J. Biol. Chem. 264:19754-19760.
27. Miyamoto, H., H. Okamoto, K. Sato, T. Tanaka, and S. Mishiro. 1992. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J. Gen. Virol. 73:715-718.
28. Monazahian, M., S. Kippenberger, A. Muller, H. Seitz, I. Bohme, S. Grethe, and R. Thomssen. 2000. Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med. Microbiol. Immunol. (Berlin) 188:177-184.
29. Patel, A. H., J. Wood, F. Penin, J. Dubuisson, and J. A. McKeating. 2000. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J. Gen. Virol. 81:2873-2883.
30. Petracca, R., F. Falugi, G. Galli, N. Norais, D. Rosa, S. Campagnoli, V. Burgio, E. Di Stasio, B. Giardina, M. Houghton, S. Abrignani, and G. Grandi. 2000. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74:4824-4830.
31. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
32. Prince, A. M., T. Huima-Byron, T. S. Parker, and D. M. Levine. 1996. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J. Viral Hepatol. 3:11-17.
33. Rice, C. M. 1996. Flaviviridae: the viruses and their replication, p. 931-959. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monach, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa.
34. Ruggieri, A., T. Harada, Y. Matsuura, and T. Miyamura. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229: 68-76.
35. Rustaeus, S., K. Lindberg, P. Stillemark, C. Claesson, L. Asp, T. Larsson, J. Boren, and S. O. Olofsson. 1999. Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation. J. Nutr. 129:463S-466S.
36. Sabile, A., G. Perlemuter, F. Bono, K. Kohara, F. Demaugre, M. Kohara, Y. Matsuura, T. Miyamura, C. Brechot, and G. Barba. 1999. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30:1064-1076.
37. Schneider, W. J., U. Beisiegel, J. L. Goldstein, and M. S. Brown. 1982. Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J. Biol. Chem. 257:2664-2673.
38. Shelness, G. S., M. F. Ingram, X. F. Huang, and J. A. DeLozier. 1999. Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly. J. Nutr. 129:456S-462S.
39. Steinberg, D. 1988. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis, vol. 18. Raven Press, Ltd., New York, N.Y.
40. Takikawa, S., K. Ishii, H. Aizaki, T. Suzuki, H. Asakura, Y. Matsuura, and T. Miyamura. 2000. Cell fusion activity of hepatitis C virus envelope proteins. J. Virol. 74:5066-5074.
41. Thomssen, R., S. Bonk, C. Propfe, K. H. Heermann, H. G. Kochel, and A. Uy. 1992. Association of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol. 181:293-300.
42. Thomssen, R., S. Bonk, and A. Thiele. 1993. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med. Microbiol. Immunol. (Berlin) 182:329-334.
43. Weisgraber, K. H., T. L. Innerarity, K. J. Harder, R. W. Mahley, R. W. Milne, Y. L. Marcel, and J. T. Sparrow. 1983. The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J. Biol. Chem. 258:12348-12354.
44. Wunschmann, S., J. D. Medh, D. Klinzmann, W. N. Schmidt, and J. T. Stapleton. 2000. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J. Virol. 74:10055-10062.
45. Yao, X. J., M. A. Wainberg, M. Richard, and M. Pollak. 1991. The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin. Antimicrob. Agents Chemother. 35:2636-2638.